CD274 and cancer: Apart from BCG treatment and PD-1/PD-L1 blockades, other immunotherapy schemes such as cytokine therapy (N-803) [31], recombinant oncolytic virus therapy (CG0070) [32], and cancer vaccines [33] are also being developed and have gained decent results.